VCBeat (WeChat ID: vcbeat) has learned that Xiaodong Health, China’s first integrated mental health service platform, recently announced it had secured strategic investment from Guangzhou Ranxin. Concurrently, Mr. Zeng Guoshu, founder of Ranxin, has been appointed as Co-Founder of Xiaodong Health, where he will be fully responsible for building the company’s pharmaceutical supply chain and strategizing its upstream and downstream pharmaceutical industry layout.
Xiaodong Health is China’s first national high-tech enterprise to apply big data and artificial intelligence technologies to the diagnosis and treatment of mental and psychological disorders. It has established an integrated, closed-loop service ecosystem encompassing online screening, online consultations, prescription refills, medication delivery, out-of-hospital rehabilitation, psychological counseling, as well as medical insurance services and mental health big data analytics.
Xiaodong Health’s internet hospital is the first platform in China to obtain a license for a specialized psychiatric and psychological internet hospital since the National Health Commission implemented the Administrative Measures for Internet Hospitals. It has also obtained certification for providing internet drug information services and Level 3 Classified Protection of Cybersecurity, ensuring the legality of medical practice, the security of pharmaceutical transactions, and the privacy of user information.
Xiaodong Health’s independently developed auxiliary diagnostic system for mental and psychological disorders has been clinically deployed in over 1,000 medical institutions across China, including the PLA General Hospital (301 Hospital), Beijing Anding Hospital affiliated with Capital Medical University, the PLA Air Force General Hospital, Beijing Friendship Hospital affiliated with Capital Medical University, the First Hospital of China Medical University, Renmin Hospital of Wuhan University, and the Guangzhou Brain Hospital affiliated with Guangzhou Medical University. The system also serves more than 3,000 entities in the military, education, judicial, and corporate sectors, and provided psychological services for the 70th Anniversary National Day Parade. It is currently the most widely used psychological screening and diagnostic tool in China, serving nearly 10 million individuals annually.
“We are honored to introduce strategic investment from Guangzhou Ranxin. This financing will strongly promote Xiaodong Health’s integrated service industry layout. Mr. Zeng Guoshu has significant influence in the psychiatric industry and a profound understanding of pharmaceutical layouts for the central nervous system. It is a great honor to work alongside Mr. Zeng Guoshu to open a new chapter in Xiaodong Health’s development,” stated Ms. Wang Huiying, Founder and Chairwoman of Xiaodong Health. “The report of the 19th National Congress of the Communist Party of China pointed out the need to strengthen the construction of a social psychological service system and cultivate a social mindset characterized by self-esteem, confidence, rationality, peace, positivity, and progress. Xiaodong Health’s vision is to contribute to social harmony and people’s well-being. We consistently adhere to the ‘Technology + Data + Service’ model to empower physicians, enhance the identification of mental and psychological disorders, and reduce recurrence rates. As pharmacotherapy is a crucial component of psychiatric rehabilitation, we are actively committed to popularizing medication knowledge among the public and leveraging big data to guide patients and their families in the scientific use of medications.”
As an investor in this funding round, Mr. Zeng Guoshu, Founder of Guangzhou Ranxin, stated: “High misdiagnosis and relapse rates are critical pain points in the mental health industry. Guangzhou Ranxin has been committed to strategic investments in central nervous system (CNS) pharmaceuticals and has accumulated extensive data on evidence-based medication practices. By leveraging Xiaodong Health’s ‘Internet + Healthcare’ model, we can effectively utilize this data to reduce disease relapse rates and adverse drug reactions, thereby better serving the public. The Xiaodong Health team has long specialized in the mental health segment, possessing a strong service-oriented culture, profound insights into industry development, and robust execution capabilities. We are highly optimistic about Xiaodong Health’s growth and will provide our full support, contributing to social harmony and public well-being.”
It is also reported that Xiaodong Health will establish the Institute of Psychological Big Data, participate in government and university-related research projects, and actively promote the development of a social psychological service system. Dr. Tian Lin, co-founder, will serve as the Chief Dean. Dr. Tian holds a bachelor’s and master’s degree in Psychology from Peking University, a Ph.D. in Psychology from Tsinghua University, and completed postdoctoral research at the School of Social Sciences, Tsinghua University. He previously served as Executive Director of the XinNeng Technology Laboratory at Tsinghua University.